A recent decision by the U.S. District Court for the District of New Jersey will likely cause a delay in a generic version of the drug Seroquel, a drug utilized in treating schizophrenia, from…

After a slight stall last week, the U.S. House of Representatives on September 7, 2007 passed the Patent Reform Act, HR 1908, with a vote of 220 to 175. On September 10, 2007, the Bill passed to the U.S. Senate for review where it is expected to undergo further debate and editing and result in a different version.

U.S. Patent Office data reveals that North Carolina ranked 15th out of 20 states named in the nation in the number of patents issued to the State’s residence during fiscal year 2006, ending…

The India patent office dismissed Novartis’ patent for cancer drug Gleevec.

Apotex, Inc. of Canada can no longer pursue its current plan to bring a generic version of Plavix into the U.S. market, now that the District Court Judge in the Southern District of New York upheld…

In May 2006, Ariad Pharmaceuticals Inc., won a $65.2 million verdict from Eli Lilly & Company after a jury decided Lilly infringed on a patent licensed to Ariad by Harvard, MIT and the Whitehead Institute for Biomedical Research. In addition to the $65 million in back royalties, Lilly will have to pay $17.8 million per year in royalties until the patent expires in 2019.